Source: Clinica Chimica Acta. Unidades: FCF, HU
Subjects: HIPERCOLESTEROLEMIA, POLIMORFISMO
ABNT
WILLRICH, Maria Alice Vieira et al. CYP3A5*3A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia. Clinica Chimica Acta, v. 398, n. 1-2, p. 15-20, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.cca.2008.07.032. Acesso em: 02 nov. 2024.APA
Willrich, M. A. V., Hirata, M. H., Genvigir, F. D. V., Arazi, S. S., Rebecchi, I. M. M., Rodrigues, A. C., et al. (2008). CYP3A5*3A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia. Clinica Chimica Acta, 398( 1-2), 15-20. doi:10.1016/j.cca.2008.07.032NLM
Willrich MAV, Hirata MH, Genvigir FDV, Arazi SS, Rebecchi IMM, Rodrigues AC, Bernik MMS, Dórea EL, Bertolami MC, Faludi AA, Hirata RDC. CYP3A5*3A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia [Internet]. Clinica Chimica Acta. 2008 ; 398( 1-2): 15-20.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.cca.2008.07.032Vancouver
Willrich MAV, Hirata MH, Genvigir FDV, Arazi SS, Rebecchi IMM, Rodrigues AC, Bernik MMS, Dórea EL, Bertolami MC, Faludi AA, Hirata RDC. CYP3A5*3A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia [Internet]. Clinica Chimica Acta. 2008 ; 398( 1-2): 15-20.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.cca.2008.07.032